Nantahala Capital Management, LLC
Position in ABEO — Abeona Therapeutics Inc.
CIK 1472322
New Canaan, CT
Position in ABEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$22,458,472
-$3,696,812 QoQ
Shares Held
5,013,052
+1.0% QoQ
Ownership
8.80%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Derivatives in ABEO
reported options exposure · as of Mar 31, 2026CallValue
$4,569,600
CallShares
1,020,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Nantahala Capital Management, LLC holds $573,882,961 across 52 Biotechnology names. ABEO ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SLNO |
Soleno Therapeutics Inc
|
1,744,124 | $58,393,271 | |
| 2 | SVRA |
Savara Inc
|
7,344,783 | $40,102,515 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
1,250,452 | $26,159,455 | |
| 4 | LBRX |
Lb Pharmaceuticals Inc
|
1,052,894 | $25,964,366 | |
| 5 | MLYS |
Mineralys Therapeutics, Inc.
|
895,481 | $24,258,580 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
2,521,936 | $23,504,443 | |
| 7 | FULC |
Fulcrum Therapeutics, Inc.
|
3,050,040 | $23,393,806 | |
| 8 | ABEO |
Abeona Therapeutics Inc.
This page
|
5,013,052 | $22,458,472 |
All Filings in ABEO
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,873,568 | 5,775,350 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $4,569,600 | 1,020,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $22,458,472 | 5,013,052 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,740,400 | 520,000 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $26,155,284 | 4,963,052 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $24,101,431 | 4,564,665 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $2,745,600 | 520,000 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $2,953,600 | 520,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $24,819,697 | 4,369,665 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,706,886 | 3,509,850 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $2,475,200 | 520,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $2,896,400 | 520,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $19,657,721 | 3,529,214 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,286,400 | 520,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $21,694,265 | 3,432,637 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,204,800 | 520,000 | Call | Sole | 2024-08-20 | |
| 2024-06-30 | $14,712,956 | 3,470,037 | Shares | Sole | 2024-08-20 | |
| 2024-03-31 | $3,770,000 | 520,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $16,752,140 | 2,310,640 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,605,200 | 520,000 | Call | Sole | 2024-02-15 | |
| 2023-12-31 | $11,273,762 | 2,250,252 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $218,920 | 52,000 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $9,673,712 | 2,297,794 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,649,576 | 1,401,880 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $80,600 | 20,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $4,028,863 | 1,428,675 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $840,011 | 272,731 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||